Membranous glomerulonephritis secondary prevention

Jump to navigation Jump to search

Membranous glomerulonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Membranous glomerulonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

Ultrasound

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Membranous glomerulonephritis secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Membranous glomerulonephritis secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Membranous glomerulonephritis secondary prevention

CDC on Membranous glomerulonephritis secondary prevention

Membranous glomerulonephritis secondary prevention in the news

Blogs on Membranous glomerulonephritis secondary prevention

Directions to Hospitals Treating Membranous glomerulonephritis

Risk calculators and risk factors for Membranous glomerulonephritis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Ahsan Hussain, M.D.[2]

Overview

Early detection and treatment of hepatitis C can be preventive for developing membranous glomerulopathy. Safe sexual practice can prevent the risk of HIV which can eventually decreases the risk of MN. Safe sexual practice can prevent the risk of syphilis which can be preventive the risk of MN.

Secondary Prevention

  • Effective measures for primary prevention of membranous glomerulonephritis include:[1][2]
    • The treatment of hepatitis C can lower the risk for membranous glomerulonephritis.[3]
    • Safe sexual practice can prevent the risk of HIV which can eventually decreases the risk of MN.[4]
    • Safe sexual practice can prevent the risk of syphilis which can be preventive the risk of MN.[5]

References

  1. Lai, Kar Neng; Li, Philip K.T.; Lui, Siu Fai; Au, Tak Cheong; Tam, John S.L.; Tong, Kwok Lung; Lai, Fernand Mac-Moune (1991). "Membranous Nephropathy Related to Hepatitis B Virus in Adults". New England Journal of Medicine. 324 (21): 1457–1463. doi:10.1056/NEJM199105233242103. ISSN 0028-4793.
  2. Gyapay G, Jeney A, Lapis K (1985). "Drug action and chromatin structure. I. Adriamycin binding to core particle of nucleosomes and subsequent enhanced DNA fragmentation induced by micrococcal nuclease". Neoplasma. 32 (5): 521–8. PMID 4069286.
  3. Gyapay G, Jeney A, Lapis K (1985). "Drug action and chromatin structure. I. Adriamycin binding to core particle of nucleosomes and subsequent enhanced DNA fragmentation induced by micrococcal nuclease". Neoplasma. 32 (5): 521–8. PMID 4069286.
  4. Simon, Viviana; Ho, David D; Abdool Karim, Quarraisha (2006). "HIV/AIDS epidemiology, pathogenesis, prevention, and treatment". The Lancet. 368 (9534): 489–504. doi:10.1016/S0140-6736(06)69157-5. ISSN 0140-6736.
  5. Chen YF, Ding JP, Yan HJ, Lu J, Ding P, Chen GH, Li JJ, Huan XP, Yang HT, Tang WM, Fu GF (2017). "The current status of syphilis prevention and control in Jiangsu province, China: A cross-sectional study". PLoS ONE. 12 (8): e0183409. doi:10.1371/journal.pone.0183409. PMC 5570431. PMID 28837587.

Template:WH Template:WS